CoChat

Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver

Open access

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Liver fibrosis is the common response to chronic liver injury, and leads to cirrhosis and its complications. Persistent inflammation is a driving force of liver fibrosis progression. Mucosal-associated invariant T (MAIT) cells are non-conventional T cells that display altered functions during chronic inflammatory diseases. Here, we show that circulating MAIT cells are reduced in patients with alcoholic or non-alcoholic fatty liver disease-related cirrhosis while they accumulate in liver fibrotic septa. Using two models of chronic liver injury, we demonstrate that MAIT cell-enriched mice show increased liver fibrosis and accumulation of hepatic fibrogenic cells, whereas MAIT cell-deficient mice are resistant. Co-culture experiments indicate that MAIT cells enhance the proinflammatory properties of monocyte-derived macrophages, and promote mitogenic and proinflammatory functions of fibrogenic cells, via distinct mechanisms. Our results highlight the profibrogenic functions of MAIT cells and suggest that targeting MAIT cells may constitute an attractive antifibrogenic strategy during chronic liver injury.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-04450-y

Cites

Statistics

Figures

Fig. 1 Frequency and functions of circulating MAIT cells are impaired during cirrhosis. a Representative dot plots showing reduction of CD161hi Vα7.2+ double positive (MAIT) cells in PBMC and summary data from cirrhotic patients (n = 74), as compared to that in healthy donors (n = 47), and repartition of cirrhotic patients into disease etiology (alcoholic cirrhosis, n = 63 and NASH cirrhosis, n = 11) and severity (compensated cirrhosis, n = 15 and decompensated cirrhosis, n = 59). Representative dot plots and cumulative data of b increased surface expression of CD25 and CD69 on MAIT cells from healthy donors (n = 25) and cirrhotic patients (n = 29) and c cytokine profile of cirrhotic (n = 20–23) vs. healthy (n = 13–16) blood MAIT cells. Statistical analysis was performed using Mann–Whitney (a, b, c) or Kruskal–Wallis followed by Dunn’s post test analysis (a). **p ≤ 0.01; ****p ≤ 0.0001; ns p > 0.05
Fig. 1 Frequency and functions of circulating MAIT cells are impaired during cirrhosis. a Representative dot plots showing reduction of CD161hi Vα7.2+ double positive (MAIT) cells in PBMC and summary data from cirrhotic patients (n = 74), as compared to that in healthy donors (n = 47), and repartition of cirrhotic patients into disease etiology (alcoholic cirrhosis, n = 63 and NASH cirrhosis, n = 11) and severity (compensated cirrhosis, n = 15 and decompensated cirrhosis, n = 59). Representative dot plots and cumulative data of b increased surface expression of CD25 and CD69 on MAIT cells from healthy donors (n = 25) and cirrhotic patients (n = 29) and c cytokine profile of cirrhotic (n = 20–23) vs. healthy (n = 13–16) blood MAIT cells. Statistical analysis was performed using Mann–Whitney (a, b, c) or Kruskal–Wallis followed by Dunn’s post test analysis (a). **p ≤ 0.01; ****p ≤ 0.0001; ns p > 0.05CC BY · PubMed Central
Fig. 2 Frequency and functions of liver MAIT cells are impaired during cirrhosis. a Representative dot plots and summary data of CD161hi Vα7.2+ double positive cells (MAIT) in mononuclear cells isolated from cirrhotic (n = 13) and control (n = 11) liver tissues. b Representative images of CD3+Vα7.2+ double positive cells in liver tissue sections from control (n = 4) and cirrhotic (n = 6) livers, showing the preferential presence of CD3+ Vα7.2+ cells within the fibrotic septa, and no or discrete sinusoidal immunostaining, whereas discrete sinusoidal staining is observed in control livers, both in sinusoidal space and portal tract (n = 6, double stained cells are indicated by arrows). Scale bar = 10 μm. c Representative CD3+ Vα7.2+ double immunostaining of liver tissue sections from cirrhotic livers, showing their presence close to α-SMA positive cells. Scale bar = 10 μm. d Comparison of expression of PD-1 and TIM-3 on intrahepatic MAIT cells in control (n = 10–11) and cirrhotic livers (n = 13–10). e Correlation between intrahepatic MAIT frequency and the percentage of positive MAIT cells for PD-1 (n = 13) and TIM-3 (n = 9) in cirrhotic livers. f Representative dot plots and summary data of cytokine profile of cirrhotic (n = 7) vs. control (n = 6) intrahepatic MAIT cells. Statistical analysis was performed using Mann–Whitney (a, d, f) or Spearman correlation test (e). *p ≤ 0.05; **p ≤ 0.01
Fig. 2 Frequency and functions of liver MAIT cells are impaired during cirrhosis. a Representative dot plots and summary data of CD161hi Vα7.2+ double positive cells (MAIT) in mononuclear cells isolated from cirrhotic (n = 13) and control (n = 11) liver tissues. b Representative images of CD3+Vα7.2+ double positive cells in liver tissue sections from control (n = 4) and cirrhotic (n = 6) livers, showing the preferential presence of CD3+ Vα7.2+ cells within the fibrotic septa, and no or discrete sinusoidal immunostaining, whereas discrete sinusoidal staining is observed in control livers, both in sinusoidal space and portal tract (n = 6, double stained cells are indicated by arrows). Scale bar = 10 μm. c Representative CD3+ Vα7.2+ double immunostaining of liver tissue sections from cirrhotic livers, showing their presence close to α-SMA positive cells. Scale bar = 10 μm. d Comparison of expression of PD-1 and TIM-3 on intrahepatic MAIT cells in control (n = 10–11) and cirrhotic livers (n = 13–10). e Correlation between intrahepatic MAIT frequency and the percentage of positive MAIT cells for PD-1 (n = 13) and TIM-3 (n = 9) in cirrhotic livers. f Representative dot plots and summary data of cytokine profile of cirrhotic (n = 7) vs. control (n = 6) intrahepatic MAIT cells. Statistical analysis was performed using Mann–Whitney (a, d, f) or Spearman correlation test (e). *p ≤ 0.05; **p ≤ 0.01CC BY · PubMed Central
Fig. 3 MAIT cells stimulate mitogenic functions of human hepatic myofibroblasts (HMF). a BrdU incorporation in hepatic myofibroblasts following direct and transwell co-cultures with either non-activated or activated MAIT cells. The results show the mean ± SEM of direct (n = 10) and transwell (n = 3) co-cultures, each performed with a different MAIT cell donor. b Representative dot plots showing the percentage of Ki-67+ hepatic myofibroblasts in direct and transwell co-culture with non-activated and activated MAIT cells by flow cytometry. c Representative immunofluorescence images showing expression of MR1 on hepatic myofibroblasts and no signal with control isotype. Similar results were obtained in three independent experiments. Scale bar = 10 μm. d Representative dot plots showing increased expression of MR1 on hepatic myofibroblast surface by flow cytometry, upon exposure to 1 μm Ac-6-FP. Three different cell cultures gave similar results. e DNA synthesis in hepatic myofibroblasts pretreated with MR1-neutralizing antibody or isotype, and co-cultured with either non-activated or activated MAIT cells. The results show a representative experiment and are the mean ± SEM of quadruplicate determinations. Similar results were obtained in three independent experiments with MAIT cells from three different donors (Supplementary Fig. 3b). Statistical analysis was determined using Mann–Whitney (a, e) or Kruskal–Wallis followed by Dunn’s post test analysis (a). *p ≤ 0.05; ****p ≤ 0.0001 vs. control HMF. #p ≤ 0.005 vs. HMF treated with non-activated MAIT cells
Fig. 3 MAIT cells stimulate mitogenic functions of human hepatic myofibroblasts (HMF). a BrdU incorporation in hepatic myofibroblasts following direct and transwell co-cultures with either non-activated or activated MAIT cells. The results show the mean ± SEM of direct (n = 10) and transwell (n = 3) co-cultures, each performed with a different MAIT cell donor. b Representative dot plots showing the percentage of Ki-67+ hepatic myofibroblasts in direct and transwell co-culture with non-activated and activated MAIT cells by flow cytometry. c Representative immunofluorescence images showing expression of MR1 on hepatic myofibroblasts and no signal with control isotype. Similar results were obtained in three independent experiments. Scale bar = 10 μm. d Representative dot plots showing increased expression of MR1 on hepatic myofibroblast surface by flow cytometry, upon exposure to 1 μm Ac-6-FP. Three different cell cultures gave similar results. e DNA synthesis in hepatic myofibroblasts pretreated with MR1-neutralizing antibody or isotype, and co-cultured with either non-activated or activated MAIT cells. The results show a representative experiment and are the mean ± SEM of quadruplicate determinations. Similar results were obtained in three independent experiments with MAIT cells from three different donors (Supplementary Fig. 3b). Statistical analysis was determined using Mann–Whitney (a, e) or Kruskal–Wallis followed by Dunn’s post test analysis (a). *p ≤ 0.05; ****p ≤ 0.0001 vs. control HMF. #p ≤ 0.005 vs. HMF treated with non-activated MAIT cellsCC BY · PubMed Central
Fig. 4 MAIT cells stimulate proinflammatory properties of human hepatic myofibroblasts. Analysis of intracellular cytokine production by human hepatic myofibroblasts a by FACS following direct (n = 8 experiments) or transwell (n = 6 experiments) co-cultured with either activated or non-activated MAIT cells; b by ELISA following direct co-cultures (n = 6 experiments). In each experiment, MAIT cells from different donors were used. c, d Analysis of intracellular cytokine production by human hepatic myofibroblasts co-cultured with activated or non-activated MAIT cells, following neutralization with 0.5 μg/ml of an IL-17-neutralizing antibody, 5 μg/ml of TNF-neutralizing antibody, or isotype. c FACS analysis (n = 6 experiments); d ELISA (n = 4 experiments). The results are expressed as the percentage of cytokine producing HMF in the presence of MAIT cells with neutralizing antibodies relative to those with isotype. e Analysis of IL-6 and IL-8 production by ELISA from monocyte-derived macrophages (MDM) upon direct co-culture with either activated or non-activated MAIT cells. The results show a representative experiment and are the mean ± SEM of sextuplicate determinations. Similar results were obtained in two independent co-culture experiments with both MAIT cells and MDM coming from two different donors (Supplementary Fig. 4b). Statistical significance was determined using Kruskal–Wallis followed by Dunn’s post test analysis (a–e). Comparison of HMF alone and HMF with non-activated and activated MAIT cells was performed further by Mann–Whitney test (a–e). *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001 vs. control HMF. #p ≤ 0.005 vs. HMF treated with non-activated MAIT cells
Fig. 4 MAIT cells stimulate proinflammatory properties of human hepatic myofibroblasts. Analysis of intracellular cytokine production by human hepatic myofibroblasts a by FACS following direct (n = 8 experiments) or transwell (n = 6 experiments) co-cultured with either activated or non-activated MAIT cells; b by ELISA following direct co-cultures (n = 6 experiments). In each experiment, MAIT cells from different donors were used. c, d Analysis of intracellular cytokine production by human hepatic myofibroblasts co-cultured with activated or non-activated MAIT cells, following neutralization with 0.5 μg/ml of an IL-17-neutralizing antibody, 5 μg/ml of TNF-neutralizing antibody, or isotype. c FACS analysis (n = 6 experiments); d ELISA (n = 4 experiments). The results are expressed as the percentage of cytokine producing HMF in the presence of MAIT cells with neutralizing antibodies relative to those with isotype. e Analysis of IL-6 and IL-8 production by ELISA from monocyte-derived macrophages (MDM) upon direct co-culture with either activated or non-activated MAIT cells. The results show a representative experiment and are the mean ± SEM of sextuplicate determinations. Similar results were obtained in two independent co-culture experiments with both MAIT cells and MDM coming from two different donors (Supplementary Fig. 4b). Statistical significance was determined using Kruskal–Wallis followed by Dunn’s post test analysis (a–e). Comparison of HMF alone and HMF with non-activated and activated MAIT cells was performed further by Mann–Whitney test (a–e). *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001 vs. control HMF. #p ≤ 0.005 vs. HMF treated with non-activated MAIT cellsCC BY · PubMed Central
Fig. 5 Profibrogenic properties of MAIT cells in vivo. Representative images and quantification of Sirius red and α-SMA areas, and hepatic TGF-β1 secretion in a MAIT cell-deficient (MR1−/−) mice (n = 5) and their WT littermates (n = 6) chronically administered with CCl4, b MAIT cell-enriched (Vα19TCRTg) mice (n = 9) and their WT littermates (n = 10) chronically exposed to CCl4 in two independent experiments (exp 1, n = 5 WT, n = 4 Tg; exp 2, n = 5 WT, n = 5 Tg), and c MAIT cell-enriched (Vα19TCRTg) mice (n = 9) and their WT littermates (n = 3) subjected to bile duct ligation. Scale bar = 100 μm. Statistical analysis was performed using Mann–Whitney (a, b, c). *p ≤ 0.05 vs. WT
Fig. 5 Profibrogenic properties of MAIT cells in vivo. Representative images and quantification of Sirius red and α-SMA areas, and hepatic TGF-β1 secretion in a MAIT cell-deficient (MR1−/−) mice (n = 5) and their WT littermates (n = 6) chronically administered with CCl4, b MAIT cell-enriched (Vα19TCRTg) mice (n = 9) and their WT littermates (n = 10) chronically exposed to CCl4 in two independent experiments (exp 1, n = 5 WT, n = 4 Tg; exp 2, n = 5 WT, n = 5 Tg), and c MAIT cell-enriched (Vα19TCRTg) mice (n = 9) and their WT littermates (n = 3) subjected to bile duct ligation. Scale bar = 100 μm. Statistical analysis was performed using Mann–Whitney (a, b, c). *p ≤ 0.05 vs. WTCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 49 · Cited by 232

Metadata

Authors
Hegde, P., Weiss, E., Paradis, V., Wan, J., Mabire, M., Sukriti, S., Rautou, P.-E., Albuquerque, M., Picq, O., Gupta, A. C., Ferrere, G., Gilgenkrantz, H., Kiaf, B., Toubal, A., Beaudoin, L., Lettéron, P., Moreau, R., Lehuen, A., & Lotersztajn, S.
Affiliations
  • Inserm (FR)
  • Hôpital Beaujon (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
  • Lehuen, Agnès
  • Lotersztajn, Sophie
Venue
Nature Communications
Published
2018-06-01
Volume
9
Issue
1
Pages
2146-2146
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2807359581
Cited by
232
References
49
Citations by year
2026: 20 · 2025: 29 · 2024: 22 · 2023: 34 · 2022: 34 · 2021: 31 · 2020: 36 · 2019: 18 · 2018: 7
FWCI
14.38
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Laboratoire d'Excellence Inflamex
  • Agence Nationale de la Recherche (ANR-17-CE14-0002, ANR-10-LABX-0017)
  • Institut National de la Santé et de la Recherche Médicale
  • Fondation pour la Recherche Médicale (DEQ20150331726)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
mucosal-associated invariant T cells, liver fibrosis, liver cirrhosis, alcoholic liver disease, non-alcoholic fatty liver disease, chronic liver injury, macrophages, inflammation
MeSH terms
Mucosal-Associated Invariant T Cells, Adult, Aged, Animals, Cell Count, Cells, Cultured, Female, Humans, Liver, Liver Cirrhosis, Macrophages, Male, Middle Aged, Coculture Techniques, Mice, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. https://app.cochat.ai/papers/10.1038/s41467-018-04450-y
The paper
Hegde, P., Weiss, E., Paradis, V., Wan, J., Mabire, M., Sukriti, S., Rautou, P.-E., Albuquerque, M., Picq, O., Gupta, A. C., Ferrere, G., Gilgenkrantz, H., Kiaf, B., Toubal, A., Beaudoin, L., Lettéron, P., Moreau, R., Lehuen, A., & Lotersztajn, S. (2018). Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. Nature Communications. https://doi.org/10.1038/s41467-018-04450-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.